Entwicklung von Secretin-und Glucagon-like peptide-2-Rezeptor-Antagonisten für die Tumordiagnostik

A Klußmeier - 2011 - refubium.fu-berlin.de
Die erfolgreiche Therapie einer Krebserkrankung ist häufig von einer rechtzeitigen
Diagnose und dem damit verbundenen rechtzeitigen Behandlungsbeginn abhängig. Eine …

[HTML][HTML] Secretin receptor as a target in gastrointestinal cancer: expression analysis and ligand development

A Klussmeier, S Aurich, L Niederstadt, B Wiedenmann… - Biomedicines, 2022 - mdpi.com
Secretin was originally discovered as a gastrointestinal peptide that stimulates fluid
secretion from the pancreas and liver and delays gastric emptying. In disease, a secretin …

Secretin receptors structural analysis as a potential drug target

K SINGH, V SENTHIL, AWR AROKIARAJ… - … Symposium on VIP …, 2017 - hub.hku.hk
G protein-coupled receptors (GPCRs) are pharmacologically vital, due to their role in several
diseased conditions like osteoporosis, obesity, cancer, neurodegeneration, diabetes …

[引用][C] Class B GPCRs: A hidden agonist within?(Relates to article by Dong, et al. FastForward 10 March 2006)

M Beinborn - Molecular Pharmacology, 2006 - ASPET
Class BG protein-coupled receptors (GPCRs) regulate a wide range of endocrine and
neuroendocrine functions and are endogenously stimulated by moderately large peptide …

Class B GPCRs: a hidden agonist within?

M Beinborn - Molecular pharmacology, 2006 - ASPET
Class BG protein-coupled receptors (GPCRs) regulate a wide range of endocrine and
neuroendocrine functions and are endogenously stimulated by moderately large peptide …

Rational development of a high-affinity secretin receptor antagonist

M Dong, KG Harikumar, SR Raval, JE Milburn… - Biochemical …, 2020 - Elsevier
The secretin receptor is a prototypic class B GPCR with substantial and broad
pharmacologic importance. The aim of this project was to develop a high affinity selective …

A novel secretin receptor splice variant potentially useful for early diagnosis of pancreatic carcinoma

GM Hayes, PE Carrigan, M Dong, JC Reubi, LJ Miller - Gastroenterology, 2007 - Elsevier
Background & Aims: Pancreatic and bile duct carcinomas represent highly aggressive
malignancies that evolve from secretin receptor-rich ductular cells. With premessenger RNA …

Identification of secretin, vasoactive intestinal peptide and glucagon binding sites: from chimaeric receptors to point mutations

M Waelbroeck, J Perret, P Vertongen… - Biochemical Society …, 2002 - portlandpress.com
We have identified two basic residues that are important for the recognition of secretin and
vasoactive intestinal peptide (VIP) by their respective receptors. These two peptides …

[PDF][PDF] Secretin Receptor

M PAGE - pancreapedia.org
Secretin and its receptor hold special places in history, with secretin representing the first
“hormone”, giving rise to the field of endocrinology when WM Bayliss and EH Starling …

[HTML][HTML] Mapping spatial approximations between the amino terminus of secretin and each of the extracellular loops of its receptor using cysteine trapping

M Dong, X Xu, AM Ball, JA Makhoul, PCH Lam… - The FASEB …, 2012 - ncbi.nlm.nih.gov
While it is evident that the carboxyl-terminal region of natural peptide ligands bind to the
amino-terminal domain of class B GPCRs, how their biologically critical amino-terminal …